Dimension Tacrolimus Diagnostic Cartridge Recalled for Measurement Imprecision
Siemens is recalling Dimension Tacrolimus diagnostic test cartridges (lots GA2286, GA3047, GA3171) due to confirmed measurement imprecision that could lead to incorrect drug dosing and potential organ failure or toxicity.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with confirmed imprecision in a critical drug-monitoring diagnostic test. While no illnesses or injuries have been reported, the defect poses significant risk of harm—incorrect tacrolimus measurements could result in organ rejection or toxicity. The severity score reflects substantial potential harm without reported actual injury.
Plain-English summary
Siemens Healthcare Diagnostics is recalling Dimension Tacrolimus (TAC) Flex reagent cartridges (lots GA2286, GA3047, and GA3171). These in vitro diagnostic tests measure tacrolimus levels in whole blood on Dimension clinical chemistry systems. A total of 6,035 units have been distributed worldwide and nationwide.
Siemens has confirmed imprecision in both quality control and patient samples, particularly at the low end of the measurement range. One patient sample that should have measured 2.0 ng/mL read as 0.0 ng/mL (100% negative bias), while another that should have measured 2.1 ng/mL read as 4.3 ng/mL (103% positive bias).
Tacrolimus is an immunosuppressant drug used in transplant patients. Incorrect measurement results could lead to improper dosing, potentially resulting in organ rejection if tacrolimus levels are too low or toxicity if levels are too high. The health consequences of erroneous results are described as major.
Customers using the affected cartridge lots should contact Siemens Healthcare Diagnostics, Inc. for guidance regarding the recalled product.
The recalled product
- Product
- Dimension Tacrolimus (TAC) Flex reagent cartridge-In vitro diagnostic test for the quantitative measurement of tacrolimus in human whole blood on the Dimension¿ clinical chemistry system SMN: 10700795 (DF207)
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Affected units
- 6,035
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- UDI: 00842768035425GA228622101310700795840
- 00842768035425GA304723021610700795840
- 00842768035425GA317123062010700795840. Lot Numbers: GA2286
- GA3047
- GA3171
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · measurement error
See all →- HighPhilips Evolution Upgrade 1.5T MRI Stiffness Calculation Error
FDA (Devices) · 2026-05-06
- ModeratePhilips MR 7700 MRE Upgrade MRI Equipment Stiffness Value Error Risk
FDA (Devices) · 2026-05-06
- ModeratePhilips MR 7700 MR Elastography device stiffness value error recall
FDA (Devices) · 2026-05-06
- ModeratePhilips SmartPath to Ingenia Elition X MR Elastography Stiffness Value Errors
FDA (Devices) · 2026-05-06
- ModeratePhilips Achieva 1.5T MRI System MRE Protocol Parameter Error Recall
FDA (Devices) · 2026-05-06